EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Cucurbitacin B from Cucurbitaceae Plants: Treating Pancreatic Cancer via Inducing Mitophagy, Inhibiting Glycolysis, and Enhancing Immune Function

Dongge Yin, Hongyue Chen, Xiaohong Jing, Shuting Lin, Yufei Sun, Rongrong Chang, Yang Feng, Xiaoxv Dong iD, Changhai Qu, Jian Ni, Xingbin Yin iD

Nutrients · 2025

DOI: 10.3390/nu17172809 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nutrients, 2025. Verfasst von Dongge Yin und 10 weiteren Autor:innen. Beteiligte Einrichtung: School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing 102488, China. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Glycolysis, Mitophagy, Triterpenes. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the National Natural Science Foundation of China, the Young Elite Scientists Sponsorship Program by the Beijing Natural Science Foundation, Beijing Natural Science Foundatio.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Cucurbitacin B (CuB) is a relatively unique and valuable component in plants of the Cucurbitaceae family due to its diverse and remarkable physiological activities, but its specific mechanisms in regulating tumor metabolism and immune response remain unclear. The hypoxic tumor microenvironment (TME) of pancreatic cancer induces metabolic reprogramming in cancer cells, causing them to rely on glycolysis for energy. LDHA, a key enzyme in glycolysis, can suppress glycolysis and tumor growth when inhibited.

Objective

The objective of this study was to investigate the mechanism of CuB against pancreatic cancer and its effect on the immune system.

Methods

In this study, cell migration/invasion assays, immunofluorescence, ELISA, Western blot, CETSA, flow cytometry, mouse models, and metabolomic and transcriptomic analyses were utilized to systematically elucidate the mechanism by which CuB inhibits pancreatic cancer and activates the immune system.

Results

This study confirms that CuB inhibits pancreatic cancer by suppressing the PI3K/Akt/mTOR pathway and activating PINK1/Parkin to induce mitophagy, thereby inhibiting cell migration, invasion, and proliferation. It downregulates the expression of LDHA to block glycolysis, reduce lactate production and efflux, and improve the acidic TME. CuB also induces ICD to activate dendritic cells, promote CD8+ T-cell and M1 macrophage infiltration, and reduce the levels of regulatory T cells. Metabolomic and transcriptomic analyses validate CuB’s dual effects on metabolic reprogramming and immune activation.

Conclusions

This study, for the first time, reveals that CuB induces mitophagy via the PI3K/Akt/mTOR and PINK1/Parkin pathways to selectively eliminate damaged mitochondria and suppress tumor energy metabolism. CuB inhibits pancreatic cancer through a triple mechanism—inducing mitophagy, inhibiting glycolysis, and activating immunity—which provides innovative insights for pancreatic cancer therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pancreatic NeoplasmsGlycolysisMitophagyTriterpenesCucurbitaceaeAntineoplastic Agents, PhytogenicAnimalsMiceTumor MicroenvironmentCell Line, TumorHumansCell ProliferationCell MovementSignal TransductionProto-Oncogene Proteins c-aktTOR Serine-Threonine KinasesPhosphatidylinositol 3-Kinases

Stichwörter der Autor:innen

Cucurbitacin Bglycolysisimmunitymitophagypancreatic cancer

Substanzen

Triterpenescucurbitacin BProto-Oncogene Proteins c-aktTOR Serine-Threonine KinasesPhosphatidylinositol 3-KinasesAntineoplastic Agents, Phytogenic

Autor:innen und Institutionen

  • School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing 102488, China.

ORCID-Profile: Xiaoxv Dong, Xingbin Yin

Förderung

  • the National Natural Science Foundation of China
  • the Young Elite Scientists Sponsorship Program by the Beijing Natural Science Foundation
  • Beijing Natural Science Foundatio
  • National Natural Science Foundation of Chinan

Zitieren

APA

Yin, D., Chen, H., Jing, X., Lin, S., Sun, Y., Chang, R., Feng, Y., Dong, X., Qu, C., Ni, J., & Yin, X. (2025). Cucurbitacin B from Cucurbitaceae Plants: Treating Pancreatic Cancer via Inducing Mitophagy, Inhibiting Glycolysis, and Enhancing Immune Function. Nutrients. https://doi.org/10.3390/nu17172809

Vancouver

Yin D, Chen H, Jing X, Lin S, Sun Y, Chang R, et al. Cucurbitacin B from Cucurbitaceae Plants: Treating Pancreatic Cancer via Inducing Mitophagy, Inhibiting Glycolysis, and Enhancing Immune Function. Nutrients. 2025. doi:10.3390/nu17172809

BibTeX
@article{Yin2025,
  author = {Yin, Dongge and Chen, Hongyue and Jing, Xiaohong and Lin, Shuting and Sun, Yufei and Chang, Rongrong and Feng, Yang and Dong, Xiaoxv and Qu, Changhai and Ni, Jian and Yin, Xingbin},
  title = {Cucurbitacin B from Cucurbitaceae Plants: Treating Pancreatic Cancer via Inducing Mitophagy, Inhibiting Glycolysis, and Enhancing Immune Function},
  journal = {Nutrients},
  year = {2025},
  doi = {10.3390/nu17172809}
}
Kostenlos starten →